Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Immunoglobulin
Sort By
Newest First
1 / 1
1 / 1
Plasma Proteins
Therapeutic Potential of Novel Plasma Protein Production Technology
David Holliday, DMS; Mark Krause
Evolve Biologics
PAP-Q3-20-CL-029
Sep 29, 2020
FDA Approval
Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies
Grifols
PR-M07-19-NI-018
Jul 09, 2019
